INSIGHTS ON PHARMACEUTICAL PACKAGING

• New Standards For Elastomeric Components In Sterile Packaging

  USP’s new elastomeric packaging standards shift testing to full system‑level evaluation, strengthen integrity and usability expectations, and place compliance responsibility on drug developers.

• Beyond The Instrument: How To Build A Defensible CCIT Method Selection Strategy

  Selecting the right CCIT strategy starts with defining leakage risks and defect limits. Matching test methods to package design supports compliance, lifecycle needs, and patient safety.

• How Adept Formulation Helps Overcome Manufacturability Challenges

  Initial development, scaleup, and tech transfer of complex multi-particulate drug systems requires meticulous planning to mitigate manufacturing risks.

• Vial Containment Systems Based On Elastomer 4031/45 Gray

  Examine the results of two, two-year studies that indicate good container closure integrity performance that can be achieved with stoppers of a given elastomer, independent of configuration.

• Future-Proof Stick Pack Packaging For Pharma 4.0

  9/3/2026

  Flexible stick pack production supports powders, granules, and liquids while enabling faster changeovers. See how controls and digital connectivity help prepare packaging operations for Pharma 4.0.

• Start Packaging Development Early: De-Risk Before You Build

  8/31/2026

  When packaging development follows fill/finish line selection rather than informing it, teams face avoidable retrofits and delays. This article examines why earlier alignment changes outcomes.

• Enabling Complex Phase IIa Dosing Through Flexible Clinical Packaging Design

  5/6/2026

  Discover how flexible, patient‑centric clinical packaging supports complex Phase IIa dosing while protecting timelines, ensuring compliance, and avoiding costly primary packaging changes.

• Designing Robust Studies To Meet Auto-Injector Performance Requirements

  10/30/2025

  Learn more about the critical tests for ensuring the proper performance of auto-injectors, which are used for a variety of applications ranging from emergency use to treating chronic conditions.

• Integrated Solutions Mitigating Challenges PosedBy RNA-Based Drugs

  7/2/2026

  Safeguard RNA drug stability with an integrated manufacturing strategy. Combining specialized analytics, advanced packaging, and precision assembly ensures molecular integrity and efficient production.